OncoSec Medical Inc (ONCSQ)

[Titan V]

Would new combos be PIIM-based or EP+Tavo like PISCES is what I often wonder. If latter, they can start from a p2 study but if former, from p1. However PIIM-based trials are likely to be more potent.

Ideally they should start multiple p1 PIIM-based trials but that would only be possible with financial backing from MRK or someone else in the form of an upfront payment. I find it unlikely that they will have to wait until conclusion of PISCES to see some of these other trials started. We’ll see.